Specimen shrinkage and its influence on margin assessment in breast cancer

被引:60
作者
Yeap, Badrul H. [1 ]
Muniandy, Suseela [1 ]
Lee, Suk-Kam [1 ]
Sabaratnam, Subathra [1 ]
Singh, Manjit [1 ]
机构
[1] Penang Gen Hosp, Dept Gen Surg, George Town, Malaysia
关键词
breast cancer; histological fixation; specimen shrinkage; tumour-free margin;
D O I
10.1016/S1015-9584(08)60020-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
OBJECTIVE: The determination of tumour-free margin in breast cancer is crucial in deciding subsequent patient management. To exemplify the phenomenon of margin contraction during specimen preparation for histopathological analysis, we quantified the shrinkage of breast specimens as a result of formalin Fixation. METHODS: Fifty consecutive mastectomy and wide excision specimens were prospectively appraised. The closest free margin and maximal turnout diameter of fresh, unprepared specimens were recorded. These measurements were compared with the corresponding parameters following tissue Fixation. RESULTS: Following formalin fixation, the mean closest free margin of the specimens was found to have decreased from 10.28 mm to 6.78 mm (34%). The reduction of the mean diameter of the tumour itself was less significant, from 41.74 mm to 39.88 mm (4.5%). CONCLUSION: Breast specimens undergo shrinkage after histological fixation, losing more than a third of their original closest free margin, whilst the tumour itself does not shrink substantially. This phenomenon has vital implications in the accuracy of margin analysis and consequent decisions on further management, including re-operation and the institution of adjuvant radiotherapy.
引用
收藏
页码:183 / 187
页数:5
相关论文
共 31 条
[1]  
BAKER JR, 1960, PRINCIPLES BIOL MICR
[2]  
Beck NE, 1998, BRIT J SURG, V85, P1273
[3]   MARGINS OF LUMPECTOMY FOR BREAST-CANCER [J].
CARTER, D .
HUMAN PATHOLOGY, 1986, 17 (04) :330-332
[4]  
DiBiase SJ, 1998, CANCER, V82, P2212, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2212::AID-CNCR16>3.3.CO
[5]  
2-L
[6]  
Gage I, 1996, CANCER-AM CANCER SOC, V78, P1921, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1921::AID-CNCR12>3.0.CO
[7]  
2-#
[8]  
Goldstein NS, 1999, AM J CLIN PATHOL, V111, P349
[9]  
GOULD EW, 1992, SEMIN SURG ONCOL, V8, P129
[10]  
Heimann R, 1996, CANCER-AM CANCER SOC, V78, P1722, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1722::AID-CNCR12>3.0.CO